Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations.
D000818:Animals; D001682:Biological Availability; D003505:Cyclodextrins / Q000494:pharmacology*; D003912:Dextrins / Q000494:pharmacology*; D004285:Dogs; D008297:Male; D013148:Spironolactone / Q000378:metabolism*; D013213:Starch / Q000494:pharmacology*; D047392:beta-Cyclodextrins; D047408:gamma-Cyclodextrins
D003505:Cyclodextrins; D003912:Dextrins; D047392:beta-Cyclodextrins; D047408:gamma-Cyclodextrins; D013148:Spironolactone; D013213:Starch; C031215:betadex; C023792:gamma-cyclodextrin